Precision BioSciences Inc (DTIL)
10.48
+0.64
(+6.50%)
USD |
NASDAQ |
Apr 30, 16:00
10.48
0.00 (0.00%)
After-Hours: 17:59
Precision BioSciences Cash from Investing (Quarterly): 0.042M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.042M |
| September 30, 2023 | 7.564M |
| June 30, 2023 | -1.056M |
| March 31, 2023 | -0.721M |
| December 31, 2022 | -0.632M |
| September 30, 2022 | -1.09M |
| June 30, 2022 | -0.779M |
| March 31, 2022 | -0.818M |
| December 31, 2021 | -1.505M |
| September 30, 2021 | -1.483M |
| June 30, 2021 | -1.69M |
| March 31, 2021 | -1.125M |
| Date | Value |
|---|---|
| December 31, 2020 | -1.096M |
| September 30, 2020 | -1.047M |
| June 30, 2020 | -1.785M |
| March 31, 2020 | -1.103M |
| December 31, 2019 | -5.529M |
| September 30, 2019 | -5.918M |
| June 30, 2019 | -8.137M |
| March 31, 2019 | -5.082M |
| December 31, 2018 | -9.871M |
| September 30, 2018 | -4.045M |
| June 30, 2018 | -1.128M |
| March 31, 2018 | -0.619M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-8.137M
Minimum
Jun 2019
7.564M
Maximum
Sep 2023
-1.469M
Average
-1.096M
Median
Dec 2020
Cash from Investing (Quarterly) Benchmarks
| Altimmune Inc | -7.959M |
| BioVie Inc | 0.00 |
| Adial Pharmaceuticals Inc | 0.35M |
| Gritstone Bio Inc | 38.30M |
| Humacyte Inc | -0.15M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.423M |
| Cash from Financing (Quarterly) | 2.828M |
| Free Cash Flow | -86.39M |
| Free Cash Flow Per Share (Quarterly) | -2.022 |
| Free Cash Flow to Equity (Quarterly) | -8.465M |
| Free Cash Flow Yield | -212.5% |